Tao Jiang

8.7k total citations · 2 hit papers
176 papers, 5.5k citations indexed

About

Tao Jiang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tao Jiang has authored 176 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 90 papers in Pulmonary and Respiratory Medicine and 42 papers in Molecular Biology. Recurrent topics in Tao Jiang's work include Lung Cancer Treatments and Mutations (75 papers), Cancer Immunotherapy and Biomarkers (42 papers) and Lung Cancer Research Studies (41 papers). Tao Jiang is often cited by papers focused on Lung Cancer Treatments and Mutations (75 papers), Cancer Immunotherapy and Biomarkers (42 papers) and Lung Cancer Research Studies (41 papers). Tao Jiang collaborates with scholars based in China, United States and United Kingdom. Tao Jiang's co-authors include Shengxiang Ren, Caicun Zhou, Xuefei Li, Chunxia Su, Fei Zhou, Chao Zhao, Caicun Zhou, Caicun Zhou, Caicun Zhou and Xiaoxia Chen and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Tao Jiang

166 papers receiving 5.4k citations

Hit Papers

Role of IL-2 in cancer immunotherapy 2016 2026 2019 2022 2016 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of IL-2 in cancer immunotherapy
    2016 404 citations Tao Jiang, Shengxiang Ren et al. profile →
  2. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
    2018 390 citations Zhe Yang, Nong Yang et al. Clinical Cancer Research profile →

Peers

Tao Jiang
Caicun Zhou China
Niki Karachaliou Spain
Takeshi Shimamura Japan
Marius Ilié France
Yiping Zhang China
Young Kwang Chae United States
Jing Yi United States
David S. Shames United States
Niels Reinmuth Germany
Teresa Troiani Italy
Caicun Zhou China
Tao Jiang
Citations per year, relative to Tao Jiang Tao Jiang (= 1×) peers Caicun Zhou

Countries citing papers authored by Tao Jiang

Since Specialization
Citations

This map shows the geographic impact of Tao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Jiang more than expected).

Fields of papers citing papers by Tao Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Jiang. The network helps show where Tao Jiang may publish in the future.

Co-authorship network of co-authors of Tao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Jiang. A scholar is included among the top collaborators of Tao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Jiang. Tao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Tao, Haoran Zhang, Wei Li, et al.. (2025). Dual-mode photochromic luminescence of carbon dots induced by photoinduced electron transfer. Science China Materials. 68(10). 3591–3599. 1 indexed citations
2.
Wang, Wenhao, Jing‐Li Fan, Tao Jiang, et al.. (2025). Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer. Frontiers in Pharmacology. 16. 1567527–1567527.
3.
4.
Fang, Yueping, Shengsen Zhang, Tao Jiang, et al.. (2025). Plant–Nanoparticle Interactions with g-C 3 N 4 : Regulator Development, Metabolic Responses, and Physiological Mechanisms. ACS Applied Materials & Interfaces. 17(46). 63322–63333.
5.
Jiang, Tao, Wei Zuo, Shaofeng Yuan, et al.. (2025). Machine learning driven benchtop Vis/NIR spectroscopy for online detection of hybrid citrus quality. Food Research International. 201. 115617–115617. 8 indexed citations
6.
Jiang, Tao, et al.. (2025). An advanced robotic system incorporating haptic feedback for precision cardiac ablation procedures. Scientific Reports. 15(1). 6839–6839. 1 indexed citations
7.
Jiang, Tao, et al.. (2025). Deep learning-driven Vis/NIR spectroscopic devices for fruit quality assessment: A comprehensive review. Trends in Food Science & Technology. 164. 105262–105262. 1 indexed citations
8.
Jiang, Tao, et al.. (2025). Research on an hourly heat load forecasting model for district heating systems based on heterogeneous model fusion. Case Studies in Thermal Engineering. 73. 106500–106500.
9.
Zhai, Yuanliang, Guorong Li, Tao Jiang, & Wei Zhang. (2024). P12.13.B LOCOREGIONAL BI-SPECIFIC CAR-T CELLS TARGETING CD44 AND CD133 IN RECURRENT GLIOBLASTOMA: THE FIRST IN-HUMAN CLINICAL TRIAL RESULTS. Neuro-Oncology. 26(Supplement_5). v69–v69. 1 indexed citations
10.
Ren, Shengxiang, Yaqi Chen, Anyi Liu, et al.. (2023). PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance. Science Advances. 9(21). eade4186–eade4186. 40 indexed citations
11.
Qiu, Zhiwei, Tao Jiang, Yingjie Li, Weiling Wang, & Baoxue Yang. (2023). Aquaporins in Urinary System. Advances in experimental medicine and biology. 1398. 155–177. 1 indexed citations
12.
Zhang, Li, Yaohe Wang, Chao Zhao, et al.. (2019). High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Zhao, Sha, Guanghui Gao, Wei Li, et al.. (2019). Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer. Lung Cancer. 130. 10–17. 121 indexed citations
14.
Jia, Yijun, Sha Zhao, Tao Jiang, et al.. (2019). Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice. Lung Cancer. 137. 85–93. 23 indexed citations
15.
Yang, Zhe, Nong Yang, Qiuxiang Ou, et al.. (2018). Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients. Clinical Cancer Research. 24(13). 3097–3107. 390 indexed citations breakdown →
16.
17.
Zhao, Sha, Xuefei Li, Chao Zhao, et al.. (2018). Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M. Lung Cancer. 128. 33–39. 34 indexed citations
18.
Yan, Shushan, Pengjun Zhang, Wei Xu, et al.. (2015). Serum Uric Acid Increases Risk of Cancer Incidence and Mortality: A Systematic Review and Meta‐Analysis. Mediators of Inflammation. 2015(1). 764250–764250. 69 indexed citations
19.
Ren, Hui, Jun Li, Jingjing Liu, Huiling Guo, & Tao Jiang. (2012). Anti-HER-2×anti-CD3 Bi-specific Antibodies Inhibit Growth of HCT-116 Colorectal Carcinoma Cells in Vitro and in Vivo. Asian Pacific Journal of Cancer Prevention. 13(6). 2795–2798. 5 indexed citations
20.
He, Guijin, et al.. (2008). Induction of biliary cholangiocarcinoma cell apoptosis by 103Pd cholangial radioactive stent γ-rays. Chinese Medical Journal. 121(11). 1020–1024. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caicun Zhou Breakdown of academic impact, for papers by Niki Karachaliou Breakdown of academic impact, for papers by Takeshi Shimamura Breakdown of academic impact, for papers by Marius Ilié Breakdown of academic impact, for papers by Yiping Zhang Breakdown of academic impact, for papers by Young Kwang Chae Breakdown of academic impact, for papers by Jing Yi Breakdown of academic impact, for papers by David S. Shames Breakdown of academic impact, for papers by Niels Reinmuth Breakdown of academic impact, for papers by Teresa Troiani
Rankless by CCL
2026